logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-24. All and new clients entering outpatient and inpatient treatment centres by main drug for which they ask for treatment in 2005 for those countries supplying data [see all tables in this series...]

Part(ii) New clients entering treatment by percentage of Outpatient and Inpatient treatment

CountryOpioidsCocaineCannabisAmphetaminesEcstasy
OutpatientInpatientTotalOutpatientInpatientTotalOutpatientInpatientTotalOutpatientInpatientTotalOutpatientInpatientTotal
Bulgaria46.653.433766.733.3394.45.63642.957.17100.00.01
Czech Republic55.244.836250.050.0267.532.546855.444.687062.537.58
Denmark92.57.526591.98.113594.85.271491.48.614092.37.726
Ireland77.222.870561.538.527881.818.280677.322.72286.813.291
Greece(1)55.244.8165271.428.66389.310.7215100.00.02
Cyprus78.421.68893.36.73097.62.484100.00.01100.00.02
Hungary70.929.148573.326.76089.310.7331384.715.335269.530.5341
Slovakia70.729.319850.050.0459.840.224953.746.323150.050.02
Finland64.635.4158100.00.0376.024.020070.929.1165100.00.01
Sweden48.052.025463.336.74977.023.042239.360.733350.050.010
United Kingdom(2)96.53.51997797.52.5557699.40.6859498.11.9160399.30.7562
Total90.39.72448194.95.1620393.36.71510177.222.8372487.512.51046

Notes:

 Only countries supplying data for clients entering treatment in inpatient and outpatient centres were reported. 

 (1) No cases of amphetamine treatment. 

 (2) Data collection period is 01.04.2004 to 31.03.2005. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - ST 03 and TDI - Outpatient and inpatient treatment centres. 

Page last updated: Tuesday, 13 November 2007